Immunohistochemistry (IHC): Principle, Protocol, Staining, Antibodies and Applications
Immunohistochemistry (IHC) is a widely used laboratory technique for detecting and localizing specific proteins, biomarkers, or other antigens within tissue sections. By combining antibody–antigen recognition with histological visualization, immunohistochemistry allows researchers and pathologists to determine not only whether a target is present, but also where it is located within cells and tissues.
IHC is particularly important in histopathology, cancer research, diagnostic pathology, biomarker research, neuroscience, immunology, and molecular pathology. It is commonly performed on formalin-fixed paraffin-embedded (FFPE) tissue, although frozen tissue and other specimen types can also be analyzed.
This guide explains the principle of immunohistochemistry, IHC staining steps, antigen retrieval, primary and secondary antibodies, detection systems, controls, troubleshooting, and major applications.
What Is Immunohistochemistry?
Immunohistochemistry (IHC) is an antibody-based staining technique used to identify specific antigens in tissue sections.
The basic principle is based on the highly specific interaction between an antibody and its target antigen or epitope.
When an antibody recognizes its target in a tissue section, the interaction can be visualized using an enzyme-based or fluorescent detection system.
In conventional chromogenic IHC, an enzyme such as horseradish peroxidase (HRP) can generate a colored reaction product after exposure to a chromogen such as 3,3′-diaminobenzidine (DAB). The resulting staining can then be examined using a light microscope.
In simple terms:
Tissue → Antigen retrieval → Primary antibody → Secondary antibody/detection system → Chromogen → Microscopic visualization
This workflow makes it possible to determine the location and distribution of specific proteins within tissue architecture.
Immunohistochemistry Principle
The immunohistochemistry principle relies on the selective binding of antibodies to specific molecular targets.
A typical IHC assay involves several important stages:
- Tissue fixation
- Paraffin embedding
- Sectioning
- Deparaffinization
- Antigen retrieval
- Blocking
- Primary antibody incubation
- Secondary antibody or detection system
- Chromogenic or fluorescent detection
- Counterstaining
- Microscopic examination
The exact protocol depends on the tissue, target antigen, antibody clone, fixation conditions, antigen-retrieval method, and detection platform.
Immunohistochemistry Workflow
1. Tissue Fixation
Tissue is generally fixed before processing to preserve its morphology and molecular components.
For many routine IHC applications, formalin-fixed paraffin-embedded (FFPE) tissue is used.
However, fixation can also modify proteins and mask epitopes, which is why antigen retrieval is frequently required before antibody incubation.
2. Tissue Embedding and Sectioning
After fixation and processing, tissue is embedded in paraffin and sectioned using a microtome.
Thin tissue sections are transferred onto microscope slides, often using adhesive or charged slides to improve tissue retention during staining.
3. Deparaffinization
For FFPE specimens, paraffin must be removed before antibody staining.
The sections are typically treated with an appropriate clearing agent followed by graded alcohol and water steps.
Incomplete deparaffinization can negatively affect staining quality.
4. Antigen Retrieval
Antigen retrieval is one of the most important steps in many IHC protocols.
During fixation, chemical cross-links can mask epitopes and reduce antibody accessibility. Antigen retrieval helps expose these targets again.
Two major approaches are:
- Heat-induced epitope retrieval (HIER)
- Enzymatic antigen retrieval
What Is Antigen Retrieval in Immunohistochemistry?
Antigen retrieval is a pretreatment used to restore or improve accessibility of target epitopes that may have been masked during tissue fixation.
Heat-Induced Epitope Retrieval
HIER uses heat together with a retrieval buffer. Depending on the laboratory system, heating may be performed using equipment such as a pressure cooker, microwave, steamer, or water bath.
Enzymatic Retrieval
Enzymatic retrieval uses proteolytic enzymes to modify proteins surrounding or masking the target epitope.
The optimal retrieval conditions are antigen- and antibody-dependent. An inappropriate retrieval method can produce weak staining, loss of morphology, tissue detachment, or nonspecific staining.
Primary Antibody in IHC
The primary antibody recognizes and binds directly to the target antigen.
Primary antibodies may be:
- Monoclonal antibodies
- Polyclonal antibodies
- Recombinant antibodies
Antibody selection is critical because staining quality depends on factors including:
- Antibody specificity
- Clone
- Species reactivity
- Tissue type
- Fixation
- Antigen retrieval
- Antibody concentration
- Incubation conditions
Antibody concentration is commonly optimized experimentally to obtain an appropriate balance between specific staining and background signal.
Secondary Antibody and Detection
In an indirect IHC method, the secondary antibody recognizes the primary antibody.
The secondary antibody can be linked to a detection molecule such as an enzyme or fluorescent label.
One advantage of indirect detection is signal amplification, because multiple secondary antibodies can interact with a primary antibody.
Common detection approaches include:
- Horseradish peroxidase (HRP)
- Alkaline phosphatase (AP)
- Fluorescent labels
- Polymer-based detection systems
For chromogenic IHC, HRP-based systems are frequently combined with DAB, producing a brown reaction product that can be visualized using a light microscope.
Immunohistochemistry Staining Protocol
A general IHC staining workflow can be summarized as follows:
- Tissue fixation: Preserve tissue morphology
- Paraffin embedding: Support tissue sectioning
- Sectioning: Produce thin tissue sections
- Deparaffinization: Remove paraffin
- Antigen retrieval: Improve epitope accessibility
- Blocking: Reduce nonspecific staining
- Primary antibody: Recognize target antigen
- Secondary antibody/detection: Generate detectable signal
- Chromogen: Produce visible staining
- Counterstain: Provide tissue context
- Mounting: Preserve the stained section
- Microscopy: Evaluate staining
The precise incubation times, antibody dilution, retrieval conditions, and detection chemistry should be established and validated for the specific assay rather than treated as universal parameters.
Direct vs Indirect Immunohistochemistry
Direct Immunohistochemistry
In direct IHC, the primary antibody is directly labeled with a detectable marker.
Advantages:
- Fewer staining steps
- Simple workflow
- Reduced potential for secondary-antibody cross-reactivity
Limitation: Direct detection generally provides less signal amplification than indirect approaches.
Indirect Immunohistochemistry
In indirect IHC, an unlabeled primary antibody binds the antigen and a labeled secondary antibody detects the primary antibody.
Advantages:
- Signal amplification
- Greater flexibility
- One secondary antibody can potentially be used with multiple compatible primary antibodies
Indirect detection is widely used in laboratory IHC workflows.
Positive and Negative Controls in IHC
Controls are essential for interpreting immunohistochemistry results.
A positive control contains tissue or material expected to express the target antigen. It helps demonstrate that the staining procedure and detection system are functioning correctly.
A negative control helps evaluate nonspecific staining and other background effects.
Appropriate controls are important for assay validation and reproducibility. The Histochemical Society has specifically emphasized the importance of positive and negative controls when validating IHC findings.
How to Interpret Immunohistochemistry Results
IHC interpretation is not simply a matter of identifying a slide as "positive" or "negative."
Localization
Where is the staining located?
- Nuclear
- Cytoplasmic
- Membranous
- Extracellular
Intensity
How strong is the staining?
- Weak
- Moderate
- Strong
Distribution
How widely is the target expressed?
- Focal
- Multifocal
- Diffuse
Cellular Pattern
Which cells demonstrate the staining?
The biological and diagnostic interpretation depends on the specific marker, tissue, assay, and clinical or experimental context.
Common Immunohistochemistry Applications
1. Cancer Research and Pathology
IHC is widely used to help characterize tumors and identify biomarkers.
- Tumor classification
- Differentiation of tumor types
- Identification of metastatic tumor origin
- Biomarker analysis
- Prognostic and predictive studies
2. Neuroscience
Researchers use IHC to visualize proteins and cellular markers in brain and nervous-system tissues.
- Neurons
- Astrocytes
- Microglia
- Synaptic proteins
- Neurodegenerative disease research
3. Immunology
IHC can help identify immune-cell populations and characterize protein expression within tissue microenvironments.
4. Developmental Biology
IHC allows researchers to investigate the spatial expression of proteins during tissue development and differentiation.
5. Biomarker Research
IHC is frequently used during biomarker discovery and validation.
Because antibody specificity can strongly influence experimental results, antibody validation is an important component of reliable IHC research.
IHC vs Immunofluorescence
Although both techniques use antibodies to detect targets, their visualization methods differ.
Immunohistochemistry: commonly uses chromogenic or enzyme-based detection, such as DAB, and is typically evaluated with a light microscope.
Immunofluorescence: uses fluorescent labels and is typically evaluated using a fluorescence microscope.
Both techniques can provide information about tissue localization. Immunofluorescence is often more flexible for fluorescent labeling and multiplex analysis.
Common IHC Problems and Troubleshooting
Weak or Absent Staining
Possible causes include:
- Incorrect antigen retrieval
- Low antibody concentration
- Poor antibody performance
- Excessive fixation
- Inappropriate detection system
- Loss or degradation of the target antigen
High Background Staining
Possible causes include:
- Excessive antibody concentration
- Inadequate blocking
- Nonspecific antibody binding
- Inappropriate washing
- Endogenous enzyme activity
- Cross-reactivity
Tissue Sections Detaching
Possible contributing factors include:
- Inadequate slide adhesion
- Aggressive antigen retrieval
- Tissue characteristics
- Inappropriate processing conditions
Because IHC is a multiparameter assay, troubleshooting should consider the entire workflow rather than changing only the antibody concentration.
How to Improve IHC Reproducibility
Reliable immunohistochemistry requires control of several variables.
Laboratories should document parameters such as:
- Tissue type
- Fixative
- Fixation conditions
- Antibody clone
- Antibody supplier
- Antibody dilution
- Antigen retrieval method
- Retrieval buffer
- Incubation conditions
- Detection system
- Positive control
- Negative control
Standardization and analytical validation are particularly important when IHC assays are used for clinical or diagnostic purposes.
Immunohistochemistry for FFPE Tissue
FFPE tissue is one of the most commonly encountered specimen formats in routine IHC.
FFPE samples are convenient for storage and histological analysis, but formalin fixation can cause epitope masking.
Consequently, antigen retrieval is an important component of many FFPE immunohistochemistry protocols.
The combination of FFPE processing, optimized antigen retrieval, validated antibodies, appropriate controls, and standardized detection conditions helps produce reproducible staining.
Frequently Asked Questions About Immunohistochemistry
What is immunohistochemistry used for?
Immunohistochemistry is used to detect and localize specific antigens, proteins, and biomarkers in tissue sections. It is widely used in pathology, cancer research, neuroscience, immunology, and biomarker studies.
What is the principle of IHC?
The principle of IHC is based on specific antibody–antigen binding. An antibody recognizes a target antigen in tissue, and a detection system produces a visible signal.
What is antigen retrieval in IHC?
Antigen retrieval is a pretreatment designed to improve access to epitopes that may have been masked during tissue fixation. Heat-induced and enzymatic retrieval are two major approaches.
What is the difference between primary and secondary antibodies?
The primary antibody directly recognizes the target antigen. The secondary antibody recognizes the primary antibody and can carry an enzyme or fluorescent label for detection.
What is DAB in immunohistochemistry?
DAB, or 3,3′-diaminobenzidine, is a commonly used chromogen in HRP-based IHC. It produces a brown insoluble reaction product at sites of enzyme activity.
Why are controls important in IHC?
Controls help determine whether staining is specific and whether the staining procedure is functioning correctly. Positive and negative controls are important components of IHC validation.
What tissue is commonly used for IHC?
Formalin-fixed paraffin-embedded (FFPE) tissue is commonly used for IHC, although frozen tissue and other specimen types can also be analyzed.
Is immunohistochemistry the same as immunofluorescence?
No. Both use antibody-based detection, but IHC commonly uses chromogenic or enzyme-based visualization, whereas immunofluorescence uses fluorescent labels.
Conclusion
Immunohistochemistry (IHC) is an essential technique for detecting and localizing specific antigens in tissue. Its applications range from routine histopathology and cancer research to neuroscience, immunology, and biomarker development.
Successful IHC depends on more than selecting an antibody. Tissue fixation, antigen retrieval, antibody validation, detection chemistry, controls, and standardized protocols all influence the quality and reproducibility of staining.
For research and diagnostic applications, careful assay optimization and validation are essential for obtaining interpretable and reproducible immunohistochemistry results.
Scientific References
- Ramos-Vara JA. Technical aspects of immunohistochemistry. Veterinary Pathology.
- Hofman FM, Taylor CR. Immunohistochemistry and related techniques.
- Hewitt SM, Baskin DG, Frevert CW, et al. Controls for immunohistochemistry: standards of practice for validation of immunohistochemical assays. Journal of Histochemistry & Cytochemistry. 2014;62(10):693–697.
- Fitzgibbons PL, Bradley LA, Fatheree LA, et al. Principles of analytic validation of immunohistochemical assays. Archives of Pathology & Laboratory Medicine.
- Shi SR, Shi Y, Taylor CR. Antigen retrieval immunohistochemistry: review and future prospects.
- College of American Pathologists. Principles of Analytic Validation of Immunohistochemical Assays: Guideline Update. 2024.
- Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical-based histopathology researchers.